ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 650 • 2013 ACR/ARHP Annual Meeting

    Parental Influence On Systemic Sclerosis

    Tracy M. Frech1, Richard Pimentel2, Allen D. Sawitzke3, Gopi Penmetsa4 and Jathine Wong2, 1Internal Medicine, Salt Lake City VAMC, Salt Lake, UT, 2University of Utah, Salt Lake, UT, 3Rheumatology, University of Utah Medical Ctr, Salt Lake City, UT, 4Rheumatology Division, University Of Utah Hospital, Salt lake City, UT

    Background/Purpose: A genealogic resource, the Utah Population Database (UPDB) has successfully identified systemic sclerosis (SSc) pedigrees and hereditable risk for this disease (1).  We hypothesized…
  • Abstract Number: 651 • 2013 ACR/ARHP Annual Meeting

    Growth Differentation Factor-15, a Marker Of lung disease In Systemic Sclerosis, Is Involved In Fibrosis Development But Does Not Impair Fibrosis Development

    Stijn Lambrecht1, Vanessa Smith2, Katelijne De wilde3, Julie Coudenys4, Filip De Keyser2 and Dirk Elewaut5, 1Dept of Rheumatology, Laboratory for Molecular Immunology and Inflammation, Ghent University, Ghent, Belgium, 2Department of Rheumatology, Ghent University Hospital, Ghent, Belgium, 3Deptartment of Rheumatology, Ghent University, Ghent, Belgium, 4Dept of Rheumatology, Ghent University, Ghent, Belgium, 5Rheumatology, Department of Rheumatology Ghent University Hospital, Ghent, Belgium

    Background/Purpose: It is generally known that members of the TGF-β superfamily are involved in the regulation of connective tissue biology in systemic sclerosis (SSc). Growth…
  • Abstract Number: 652 • 2013 ACR/ARHP Annual Meeting

    Pirfenidone and BIBF1120 Suppress Collagen Synthesis In Skin Fibroblast From Patients With Systemic Sclerosis

    Yuko Ota1, Yasushi Kawaguchi1, Kae Takagi1, Hisae Ichida1, Yasuhiro Katsumata1, Takahisa Gono1, Yuko Okamoto1, Tomoaki Higuchi2, Hidenaga Kawasumi1 and Hisashi Yamanaka1, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute Of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

    Background/Purpose: Pirfenidone (5-methyle-1-phenyl-2- [1H]-pyridone) and BIBF1120 (Nintedanib) are currently evaluated in clinical trials as a potential idiopathic pulmonary fibrosis (IPF). Pirfenidone was approved as the…
  • Abstract Number: 653 • 2013 ACR/ARHP Annual Meeting

    Norepinephrine-Induced IL-6 Regulates Fibrosis In Systemic Sclerosis

    Sei-ichiro Motegi, Akihito Uehara, Kazuya Yamada, Akihiko Uchiyama, Sachiko Ogino, Yoko Yokoyama, Yuko Takeuchi and Osamu Ishikawa, Department of Dermatology, Gunma University Graduate School of Medicine, Gunma, Japan

    Background/Purpose: Raynaud phenomenon is freaquently observed in patients of systemic sclerosis (SSc) and characterized by episodic vasospasm and ischemia of extremities in response to cold or…
  • Abstract Number: 654 • 2013 ACR/ARHP Annual Meeting

    Effects Of Macitentan and Its Active Metabolite In Modulating Extracellular Matrix Synthesis In Cultured Human Systemic Sclerosis and Normal Skin Fibroblasts

    Maurizio Cutolo1, Paola Montagna2, Renata Brizzolara2, Elisa Alessandri3, Pietro Paolo Tavilla4, Aurora Parodi4, Alberto Sulli5 and Stefano Soldano6, 1University of Genova, Genova, Italy, 2Department of Internal Medicine, Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy, 3Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 4Department of Endocrinologial and Medical Science, Unit of Dermatology, University of Genova, Genova, Italy, 5Research Laboratory and Academic Unit of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy, 6Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genova, Italy

    Background/Purpose: Endothelin-1 (ET-1) has been shown to activate myofibroblasts and to enhance the synthesis of extracellular matrix proteins (ECM),  such as collagen type I (COL-1)…
  • Abstract Number: 655 • 2013 ACR/ARHP Annual Meeting

    DNA Methylation and Systemic Sclerosis

    Gloria Salazar1, Khurshida Begum2, Xinjian Guo3, Minghua Wu1, Shervin Assassi1, Maureen D. Mayes1, John D. Reveille1 and Xiaodong Zhou1, 1Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 2Baylor College of Medicine, Houston, TX, 3Rheumatology, The University of Texas Medical School at Houston, Houston, TX

    DNA Methylation and Systemic SclerosisBackground/Purpose: Epigenetic modifications are stable and heritable alterations in gene expression and cellular function that do not involve changes to the…
  • Abstract Number: 656 • 2013 ACR/ARHP Annual Meeting

    Gene Expression Variation and The Role Of Interferon In Patients With Morphea From The Morphea In Adults and Children Cohort

    Daniel Grabell1, Andrew Kim2, Virginia Pascual3, Shervin Assassi4 and Heidi Jacobe1, 1Dermatology, UT Southwestern Medical Center at Dallas, Dallas, TX, 2Lenox Hill Hospital, New York, NY, 3Baylor University, Dallas, TX, 4Rheumatology, University of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: Localized scleroderma (morphea) is characterized by inflammation and sclerosis of the dermis and underlying tissue and may be associated with significant morbidity. Overproduction of…
  • Abstract Number: 657 • 2013 ACR/ARHP Annual Meeting

    Lipoic Acid Plays a Crucial Role In Scleroderma Dermal Fibroblasts

    Pei-Suen Tsou1, Beatrix Balogh2, Adam J. Pinney2, George Zakhem2, Ann Kendzicky2, Elena Schiopu3, Dinesh Khanna4, David A. Fox5 and Alisa E. Koch5,6, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI, 3Rheumatology/Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 4Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI, 5Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 6VA Medical Service, Ann Arbor, MI

    Background/Purpose: Systemic sclerosis (SSc) is a connective tissue disease characterized by vasculopathy and fibrosis of the skin and organs. Increase in oxidative stress and platelet-derived…
  • Abstract Number: 658 • 2013 ACR/ARHP Annual Meeting

    Elevated 8-Isoprostane In Scleroderma: Implications Of Its Role In Inhibiting Vascular Endothelial Growth Factor-Induced Angiogenesis

    Pei-Suen Tsou1, George Zakhem2, Beatrix Balogh2, M. Asif Amin3, Phillip Campbell4, Gautam Edhayan1, Ray Ohara2, Elena Schiopu5, Dinesh Khanna6, Alisa E. Koch3,7 and David A. Fox1, 1Internal Medicine, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI, 3Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 4Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 5Rheumatology/Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 6Division of Rheumatology, University of Michigan, Ann Arbor, MI, 7Department of Veteran's Affairs and University of Michigan, Ann Arbor, MI

    Background/Purpose: Scleroderma (SSc) is a complex disease characterized by inflammation, vasculopathy, and excessive disposition of extracellular matrix. Various studies have demonstrated a paradoxical increase in…
  • Abstract Number: 659 • 2013 ACR/ARHP Annual Meeting

    Circulating Cell-free microRNAs in Systemic Sclerosis

    Samantha Steen1, Anting L. Carlsen2, Line V. Iversen1, Christoffer T. Nielsen3, Christian Lood4, Anders A. Bengtsson4 and Niels H. H. Heegaard1, 1Department of Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark, 2Clinical Biochemistry, Immunology & Genetics, Statens Serum Institut, Copenhagen, Denmark, 3Infectious Diseases and Rheumatology, University Hospital Rigshospitalet, Copenhagen, Denmark, 4Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden

    Background/Purpose: microRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression through target mRNAs and are involved in important physiological and pathological…
  • Abstract Number: 660 • 2013 ACR/ARHP Annual Meeting

    Bleomycin Delivery By Mini-Osmotic Pump: A Novel Multi-Organ Murine Model For Fibrosis

    Rebecca Lee1, Elena Tourkina2, Richard P. Visconti3 and Stanley Hoffman4, 1Division of Rheumatology, Medical University of South Carolina, Charleston, SC, 2Rheumatology, Medical University of SC, Charleston, SC, 3Cell Biology and Regenerative Medicine, Medical University of South Carolina, Charleston, SC, 4Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Systemic sclerosis (SSc, Scleroderma) is a rare but severe systemic connective tissue disorder involving the skin and multiple internal organs, in particular lung, kidney,…
  • Abstract Number: 661 • 2013 ACR/ARHP Annual Meeting

    Topoisomerase-1 Specific T Cells Exhibit a Proinflammatory Th17 Phenotype and Are Associated With Interstitial Lung Disease In Scleroderma

    Andrea Fava1, Raffaello Cimbro1, Antony Rosen2, Qing-Rong Liu3, Fredrick M. Wigley2 and Francesco Boin2, 1Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3NIH/NIDA, Baltimore, MD

    Background/Purpose: Anti-topoisomerase-1 (Topo-1 or Scl70) autoantibodies are present in 30-45% of scleroderma (SSc) patients and identify a more aggressive disease phenotype with worse clinical outcome…
  • Abstract Number: 662 • 2013 ACR/ARHP Annual Meeting

    Oxidative Stress-Dependent Activation Of Collagen Synthesis Is Induced In Human Pulmonary Vascular Smooth Muscle Cells By Scleroderma Sera and Predicts Pulmonary Vascular Disease

    Francesco Boin1, Anna Maria Posadino2, Annalisa Cossu2, Roberta Giordo2, Ami A. Shah1, Gaia Spinetti3, Gian Luca Erre4, Costanza Emanueli5, Giuseppe Passiu4, Fredrick M. Wigley1 and Gianfranco Pintus2, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Biomedical Sciences, University of Sassari, Sassari, Italy, 3Istitituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Multi Medica, Milan, Italy, 4Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Sassari, Sassari, Italy, 5Laboratories of Vascular Pathology and Regeneration, University of Bristol, Bristol, United Kingdom

    Background/Purpose: Vascular disease is a dominant component of Systemic Sclerosis (SSc) pathogenesis. Hypoxia and oxidative stress have been linked to endothelial injury, intimal hyperplasia and…
  • Abstract Number: 625 • 2013 ACR/ARHP Annual Meeting

    Smoking and Secondhand Smoke Exposure Among Patients With Systemic Lupus Erythematosus and Controls: Associations With Disease and Disease Damage

    Samantha J. Minkin, Stephanie N. Slan, Gary S. Gilkeson and Diane L. Kamen, Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Previous reports suggest smoking may be a risk factor for developing systemic lupus erythematosus (SLE), however the significance of this relationship varies among studies.…
  • Abstract Number: 642 • 2013 ACR/ARHP Annual Meeting

    Serum Concentrations Of Type I Interferon-Regulated Chemokines Are Associated With Disease Activity In Systemic Lupus Erythematosus

    Eric F. Morand, Kathryn Connelly and Alberta Y. Hoi, Centre for Inflammatory Diseases, Monash University, Melbourne, Australia

    Background/Purpose: Expression array studies suggest the activity of Type I interferon (IFN), as reflected in IFN-induced genes, is associated with phenotypic subsets in SLE. Three…
  • « Previous Page
  • 1
  • …
  • 2204
  • 2205
  • 2206
  • 2207
  • 2208
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology